Navigation Links
Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology

PHILADELPHIA, July 21, 2014 /PRNewswire/ -- Mike Patterson, CEO of Graphene Frontiers, announced the successful closing of $1.6 million in Series Seed B funding to finance production of cutting edge biological and chemical sensors for the life science, defense, intelligence, and environmental industries.  A group affiliated with Trimaran Capital Partners led the round and was joined by R2M Investments.  Return backers include WEMBA 36 Angels.  Said Patterson, "This round of funding will ensure Graphene Frontier's position as one of the leading graphene technology companies in the world. The investment will be utilized to hire additional Ph.D. level researchers, expand laboratory facilities, and facilitate the development of Graphene Frontiers' breakthrough, proprietary sensors and manufacturing process that supports mass production for industrial and commercial uses," he noted. 

Graphene Frontiers markets its sensor technology under the six™ sensor brand name.  Observed Patterson, "our six™ brand graphene sensors will disrupt the global sensor market because of their dramatically superior technology, lower cost and ability to deliver higher quality results more efficiently." 

six™ sensor technology offers significant advantages over sensors made from other materials:

  • greater sensitivity, higher detection limits.
  • greater speed presenting diagnostic data.
  • smaller, lighter size provides breakthrough portability design possibilities.
  • label-free, all-electronic readout eliminates need for highly skilled technicians and expensive laboratory.
  • can be mass produced at a lower cost.
  • can be multi-plexed to quantify dozens of biomarkers from a single micro sample.

Graphene Frontiers was founded in 2010 as a spin-out from the University of Pennsylvania.  The company is winner of a National Science Foundation (NSF) SBIR Phase II grant to commercialize its innovative, patent pending, manufacturing process. Graphene Frontiers' proprietary chemical vapor deposition (CVD) process and etch-free film transfer works at atmospheric pressure, superior to other graphene processes, enabling mass production of graphene on a commercial scale.

Graphene is an advanced nanomaterial consisting of a carbon sheet only 1 atomic layer thick. It is the lightest, strongest, most electrically conductive material known. People have called it the "miracle material of the 21st century" because it offers superior properties to any material in current use. 

Graphene Frontiers
3624 Market Street, 5th Floor E
Philadelphia, PA  19104   USA
Phone: 267-225-5003

For additional information
or interview, contact:
Samantha Bucher +1 215.627.3030  

Logo -

SOURCE Graphene Frontiers
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A
2. LEED AP Certified ITRA Global / Customized Real Estate Services Introduces New Approach to Its Branding
3. Global and Chinese Sodium Borohydride Industry Report 2014
4. Increased Investments in New Drug Development Drives Demand for Cell-Based Assays, According to an Upcoming Report by Global Industry Analysts, Inc.
5. Global Market for Induced Pluripotent Stem Cells to Reach $2.9 Billion in 2018; Technology Offers New Hope for Regenerating Human Tissue
6. Global Cell-based Assays (Reagents & Assay Kits, Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services) Market - Forecast to 2018
7. Research Study on Lithopone Industry (China, Global Regions) Development Trends Available at
8. Global Genomics and Proteomics Analytical Instruments Market 2014-2018
9. Analysis on 1,2-Pentanediol Industry (Global, China) Development and Investment Study Now at
10. 2014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at
11. Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR
Post Your Comments:
(Date:11/24/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that ... and invited investors to participate via webcast. ... 1, 2015 at 11.00 a.m. Eastern Time --> ... 1, 2015 at 11.00 a.m. Eastern Time --> ... NY      Tuesday, December 1, 2015 at 11.00 ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... on behalf of the Toronto Stock Exchange, confirms that ... are no corporate developments that would cause the recent ... --> --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical ...
(Date:11/24/2015)... , November 24, 2015 SHPG ) announced ... in the Piper Jaffray 27 th Annual Healthcare Conference in ... 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Financial Officer, will participate in the Piper Jaffray 27 th ... NY on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 ...
(Date:11/24/2015)... ... 24, 2015 , ... In harsh industrial processes, the safety ... sensors can represent a weak spot where leaking process media is a possible ... housings , which are designed to tolerate extreme process conditions. They combine rugged ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):